• DOI:10.2165/00044011-200828040-00002
Corpus ID: 8294060

Economic Benefits of Treating High-Risk Hypertension with Angiotensin II Receptor Antagonists (Blockers)

@article{Coca2008EconomicBO,
  title={Economic Benefits of Treating High-Risk Hypertension with Angiotensin II Receptor Antagonists (Blockers)},
  author={A. Coca},
  journal={Clinical Drug Investigation},
  year={2008},
  volume={28},
  pages={211-220}
}

• A. Coca
• Published 2008
• Medicine
• Clinical Drug Investigation

Hypertension is one of the leading risk factors for cardiovascular disease and represents a major health and economic burden. Most patients with high-or very high-risk hypertension have multiple cardiovascular risk factors with or without accompanying subclinical organ damage or established cardiovascular or renal disease. Patients with severe hypertension or with moderate hypertension and one to two additional risk factors have absolute 10-year risks of cardiovascular disease of 21–30% and 15… Expand

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed